Medtronic to Acquire SPR Therapeutics for $650 Million
(May 20, 2026) Medtronic announced its plans to acquire SPR Therapeutics, a privately held medical device company that specializes in non-opioid, non-surgical, and minimally invasive solutions for acute and chronic...